Canada markets open in 2 hours 43 minutes

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
39.50-1.59 (-3.87%)
At close: 04:00PM EDT
39.50 0.00 (0.00%)
After hours: 04:20PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close41.09
Open41.16
Bid29.29 x 200
Ask39.60 x 100
Day's Range39.24 - 41.16
52 Week Range27.99 - 50.99
Volume315,251
Avg. Volume363,530
Market Cap2.98B
Beta (5Y Monthly)1.18
PE Ratio (TTM)N/A
EPS (TTM)-2.73
Earnings DateMay 07, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est58.10
  • GlobeNewswire

    Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting

    VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced two oral presentations highlighting XEN1101 clinical data at the American Academy of Neurology (AAN) 2024 Annual Meeting in Denver, CO. Mr. Ian Mortimer, Xenon’s President and Chief Executive Officer, stated, “We are excited that our abstracts focused on XEN1101, including interim data from the ongoing X-TOLE open-label extension st

  • GlobeNewswire

    Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

    VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place April 16-17, 2024. Company Presentation Details:Date: Tuesday, April 16, 2024Time: 9:30 AM Eastern TimeWebcast: Register herePresenters: Ian Mortimer, President and Chief Executive Officer A live webcast of the company present

  • GlobeNewswire

    Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

    VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 23rd Annual Needham (Virtual) Healthcare Conference taking place April 8-11, 2024. Company Fireside Chat Presentation Details: Date:Thursday, April 11, 2024 Time:3:00 PM Eastern Time Webcast:Register here Presenters:Ian Mortimer, President and Chief Executive Officer Sherry Aulin, Chief Financ